Skip to main navigation Skip to search Skip to main content

Differential TERT promoter methylation and response to 5-aza-2′-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death

  • Kerry A. Pettigrew
  • , Richard N. Armstrong
  • , Hilary A. A. Colyer
  • , Shu-Dong Zhang
  • , Irene Maeve Rea
  • , Rhiannon E. Jones
  • , Duncan M. Baird
  • , Ken I. Mills

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)768-780
JournalGenes, Chromosomes and Cancer
Volume51
Issue number8
DOIs
Publication statusPublished (in print/issue) - 2012

Bibliographical note

cited By 14

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • EMTREE drug terms: 5 aza 2' deoxycytidine
  • messenger RNA
  • telomerase reverse transcriptase
  • EMTREE medical terms: acute granulocytic leukemia
  • aged
  • article
  • cancer patient
  • cancer resistance
  • cell death
  • cell strain HL 60
  • cell strain U937
  • cell viability
  • clinical article
  • controlled study
  • CpG island
  • demethylation
  • DNA methylation
  • DNA sequence
  • enzyme activity
  • female
  • gene expression
  • genetic parameters
  • human
  • human cell
  • leukemia cell
  • lymphoma cell
  • male
  • priority journal
  • promoter region
  • protein expression
  • pyrosequencing
  • telomere length
  • MeSH: Aged
  • 80 and over
  • Antimetabolites
  • Antineoplastic
  • Azacitidine
  • Cell Death
  • Cell Line
  • Tumor
  • CpG Islands
  • DNA Methylation
  • Female
  • Gene Expression Regulation
  • Neoplastic
  • HL-60 Cells
  • Humans
  • Leukemia
  • Myeloid
  • Acute
  • Male
  • Promoter Regions
  • Genetic
  • Telomerase
  • Telomere
  • U937 Cells

Cite this